The first known lawsuit has now been filed against the makers of Dupixent (dupilumab), alleging that the popular eczema and asthma drug caused or accelerated a deadly form of lymphoma…. By: Morris James LLP
Previous Story
Dupixent Lawsuit: Litigation Update and Settlement Information
Next Story
Causation Conundrums: Implications of Georgia Supreme Court’s Interpretation of Statute of Repose in Long-Term Product Use Cases
